E-Mart24 Inc. opened its first store in Malaysia, a 257-square-meter outlet in an office district in Kuala Lumpur, on Thursday as part of its push to open 300 stores in five years in the Southeast Asian country.
The convenience store arm of South Korean retail giant Shinsegae has signed a "master franchise" contract with United Frontiers Holdings (UFH), a local food and distribution investment firm, for its foray into Malaysia.
UFH plans to open 10 E-Mart24 stores by the end of 2021 and 300 stores in five years.
The store will sell four brands of instant cup rice and Korean street foods like the Korean snack made of rice cakes and red chili pepper sauce"tteokbokki" the sweet-and-sour fried chicken called "chicken gangjeong."
It will also offer such convenience foods as "gimbap," or rice rolls with a variety of vegetables, salads, and sandwiches.
E-Mart24's brands will comprise 30 percent of all products.
It would also put up a special shelf for South Korean cosmetics products to address local interest in K-beauty.
E-Mart24's rival CU opened its first store in Kuala Lumpur in April this year.


US PCE Inflation Holds at 3.7% as Fed Rate Decision Looms
Tesla Raises Cybertruck Prices by $5,000 in US
U.S. Unleashes New Iran Sanctions, Targets Oil, Crypto and Trade Networks
Asian Energy Stocks Slide as Iran-Oman Hormuz Talks Pressure Oil Prices
SK Hynix Shares Fall as Workers Reject Wage Deal
Asian Stocks Rebound as Oil Prices Fall, Nvidia Earnings in Focus
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Bank of Korea Raises Rates to 3% as Inflation Stays Sticky
Trump Escalates Canada Trade War With 50% Tariffs
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Japan Eyes Tax Changes to Curb Condo Speculation
Mercer International Stock Surges 45% on C$20 Million Canada Funding
US Stocks Finish Flat as Inflation Data, Nvidia Earnings Keep Investors Cautious
Dollar Steady Ahead of Jackson Hole as Yen Holds Firm
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



